Sexual & Reproductive Research research peptides

The short version

Kai Peptides is a reading desk, not a store. It collects what published research actually says about two peptides that come up repeatedly in conversations about sexual desire, arousal, and skin pigmentation: PT-141 (bremelanotide) and Melanotan 2. A peptide is a short chain of amino acids — the same building blocks as proteins, only far smaller. Both of these were developed from a naturally occurring hormone signal in the brain called alpha-MSH, which acts on a family of receptors called melanocortin receptors. These receptors are involved in pigmentation, appetite, and — crucially — in the neural circuits that regulate sexual motivation and arousal.

This desk does one job: it tells you, in plain language and with citations, what each peptide was tested on, in which species, and how far that evidence actually reaches. It covers libido, arousal, tanning, and the documented safety concerns frankly, because understanding them requires honesty, not vagueness. We do not sell anything, we do not give medical advice, and we never list a human dose.

What the melanocortin system is — and why it matters here

The melanocortin system is a network of receptors — MC1R through MC5R — distributed across the skin, brain, and other tissues, responding to hormone signals from the pituitary and hypothalamus. Two of those receptors are central to this desk:

• MC1R sits mainly on melanocytes, the pigment-making cells in the skin. When it is activated, those cells produce more of the dark pigment eumelanin, producing a tan.
• MC4R is expressed in the hypothalamus and limbic system — brain areas involved in appetite, reward, and sexual motivation. When it is activated, it engages the neural circuitry of sexual desire.

Both peptides covered here activate melanocortin receptors, but with critically different selectivity. PT-141 is a selective MC4R and MC3R agonist: it acts centrally on arousal circuits and produces little pigmentation. Melanotan 2 is non-selective: it hits all five receptor subtypes at once, producing a tan and sexual effects and appetite suppression, plus a broader range of side effects. That difference in selectivity is the defining feature of this desk, and it has major practical and safety implications that the comparison page unpacks.

What are research peptides?

A research peptide is a compound that has been synthesized and studied in the laboratory — in cell cultures, animal models, sometimes early human trials — but has not been approved by a regulator as a medicine. The distinction matters because it determines what is actually known. Sellers describe such compounds as being for laboratory research only, and that framing is not merely legal language: it reflects that dosing, long-term safety, and real-world effectiveness in people are usually unestablished.

One compound on this desk crosses the line from research to approval: PT-141, under its pharmaceutical name bremelanotide, received FDA approval in 2019 for a specific, narrow indication ^[5]. Everything else, including any use of the 'PT-141 research chemical' sold outside pharmacy channels, and every use of Melanotan 2, remains in the unapproved research category. When this site reports a study finding, it follows the study's own framing — for example, studied in premenopausal women with HSDD — never as a recommendation for any individual.

A note on how this desk reads the literature

Kai Peptides is a cross-referenced literature digest. Each peptide page summarizes the peer-reviewed studies for that compound, cites them by number, and links to a single shared references list. Where the evidence is thin, from a single Phase 1 study, or preclinical only, this desk says so plainly — the caution is part of the record, not a footnote to it. This desk also covers the reported real-world experience from people in research-use communities, labeled clearly as anecdotal, not clinical evidence, because understanding how these compounds actually land in the world requires engaging that record honestly, even where it is mixed or adverse. The aim is a calm, accurate picture of what is known and what is not.